Inactive Instrument

News SourcingLink.net, Inc. OTC Bulletin Board

Stocks

US8361714053

Pharmaceuticals

All News

12/07/22	Oncology Pharma : Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System	PU
29/06/22	Oncology Pharma : Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System	PU
06/06/22	Oncology Pharma : Financial Statements (Unaudited) for the year ended March 31, 2022	PU
15/02/22	Oncology Pharma : Financial Statements for the period ended December 31, 2021	PU
15/02/22	Oncology Pharma : Disclosure Statement for the period ended December 31, 2021	PU
20/07/21	Oncology Pharma Inc :.	AQ
31/03/21	Oncology Pharma : Has Provided Initial Funding to NanoSmart Pharmaceuticals to Conduct Feasibility Studies for Initial Phases of IND-Enabling Activities	AQ
31/03/21	NanoSmart Pharmaceuticals, Inc. announced that it has received funding from Oncology Pharma Inc.	CI
16/03/21	Oncology Pharma : Reveals Strategic Plans for Company Growth and Focus	AQ
10/03/21	Oncology Pharma : Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy	AQ
10/03/21	Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy	CI
04/03/21	Oncology Pharma : Moves to Fund Lead Drug Formulation & IND-Enabling Studies	AQ
04/03/21	Oncology Pharma Inc. Moves to Fund Lead Drug Formulation & IND-Enabling Studies	CI
26/02/21	Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent	CI
26/02/21	Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent	GL
22/02/21	Oncology Pharma : Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology	AQ
22/02/21	Oncology Pharma Extends Licensing Agreement with Nanosmart Pharmaceuticals, Inc. for Veterinary Oncology	CI
16/02/21	Oncology Pharma : is Pleased to Welcome New Chairman to Its Scientific Advisory Board	AQ
16/02/21	Oncology Pharma Inc. Announces Henry Smith as New Chairman to Its Scientific Advisory Board	CI
09/02/21	Oncology Pharma Renews Licensing Agreement with Ribera Solutions LLC for Its Connect2med Clinical Trials Platform	CI
09/02/21	Oncology Pharma : Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform	AQ
03/02/21	Oncology Pharma : Extends Its Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Human Oncology	AQ
29/01/21	Oncology Pharma Announces the Appointment Of New Chief Financial Officer	GL
29/01/21	Oncology Pharma Announces the Appointment of James Smith as New Chief Financial Officer	CI
11/12/20	Oncology Pharma Inc. cancelled the acquisition of acquire 50% stake in Diagnomics, Inc.	CI